Overview of Dr. Pinilla-Ibarz
Dr. Javier Pinilla-Ibarz is an oncologist in Tampa, FL and is affiliated with H. Lee Moffitt Cancer Center and Research Institute. He received his medical degree from Universidad de Zaragoza Faculty of Medicine and has been in practice 29 years. Dr. Pinilla-Ibarz accepts several types of health insurance, listed below. He is one of 171 doctors at H. Lee Moffitt Cancer Center and Research Institute who specialize in Oncology. He has more than 100 publications and over 500 citings.
Office
12902 USF Magnolia Dr
Tampa, FL 33612- Is this information wrong?
Education & Training
- New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2004 - 2006
- Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2001 - 2004
- Universidad de Zaragoza Faculty of MedicineClass of 1988
Certifications & Licensure
- FL State Medical License 2006 - 2025
- American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
Clinical Trials
- Study Safety and Preliminary Efficacy of DCC-2036 in Patients With Leukemias (Ph+ CML With T315I Mutation) Start of enrollment: 2009 Mar 01
- Ofatumumab, High Dose Methylprednisolone, Ofatumumab and Lenalidomide Consolidative Therapy for Untreated CLL/SLL Start of enrollment: 2012 Mar 30
- Ruxolitinib in Combination With Nilotinib in Chronic Myeloid Leukemia (CML) Patients Start of enrollment: 2013 Feb 21
- Join now to see all
Publications & Presentations
PubMed
- Incidence of pleural effusion with dasatinib and the effect of switching therapy to a different TKI in patients with chronic phase CML.Lisa Nodzon, Amanda Rodriguez, Akriti G Jain, Quinto Gesiotto, Somedeb Ball, Onyee Chan, Eric Padron, Andrew Kuykendall, Rami Komrokji, David A Sallman, Jeffrey E Lanc...> ;Annals of Hematology. 2024 Apr 18
- Baseline Serum Inflammatory Proteins Predict Poor CAR T Outcomes in Diffuse Large B-cell Lymphoma.Dean, E., Rawan G Faramand, Sae Bom Lee, Michael D Jain, Biwei Cao, Xuefeng Wang, Kai Rejeski, Marion Subklewe, Johannes F Fahrmann, Neeraj Y Saini, Samir M Hanash, Yu...> ;Blood Cancer Discovery. 2024 Mar 1
- Long-term follow up of the combination of ofatumumab, high-dose methylprednisolone, and lenalidomide for untreated chronic lymphocytic leukemia with biomarker analysis.Julio C Chavez, Ariel Grajales, Jose Sandoval-Sus, Elyce Turba, Lisa Nodzon, Angimar Uriepero-Palma, Mohammad Ammad-Ud-Din, Eva Sahakian, Rami Komrokji, Lubomir Sokol,...> ;Clinical Lymphoma, Myeloma & Leukemia. 2024 Feb 13
- Join now to see all
Journal Articles
- A Phase I Clinical Trial of Ruxolitinib in Combination with Nilotinib in Chronic Myeloid Leukemia Patients with Molecular Evidence of DiseaseKendra Sweet, Fadi Kayali, Javier Pinilla-Ibarz, Leukemia Research
- A Phase I Clinical Trial of Ruxolitinib in Combination with Nilotinib in Chronic Myeloid Leukemia Patients with Molecular Evidence of DiseaseKendra Sweet, Fadi Kayali, Javier Pinilla-Ibarz, Leukemia Research
Abstracts/Posters
- Moffitt Cancer Center 2-Year Single-Institution Experience with Next-Generation Sequencing Minimal Residual Disease Detection: Clinical Utility, Application, and Corre...Javier Pinilla Ibarz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Selective Targeting of Histone Deacetylase 11 Disables Metabolism of Myeloproliferative NeoplasmsJavier Pinilla Ibarz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Patient-Reported Outcome Results from the U.S. Life after Stopping TKIs (LAST) Study in Patients with Chronic Myeloid LeukemiaJavier Pinilla Ibarz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Join now to see all
Authored Content
- A Phase I Clinical Trial of Ruxolitinib in Combination with Nilotinib in Chronic Myeloid Leukemia Patients with Molecular Evidence of DiseaseOctober 2018
Press Mentions
- Precigen Announces Clearance of IND to Initiate Phase 1/1b Study for PRGN-3007 UltraCAR-T® in Advanced ROR1+ Hematological and Solid TumorsOctober 26th, 2021
- Experts Emphasize Importance of Preventing Progression in CMLJanuary 29th, 2016
- Mutation Analysis in Chronic Myeloid LeukemiaJanuary 14th, 2016
- Join now to see all
Hospital Affiliations
- H. Lee Moffitt Cancer Center and Research InstituteTampa, Florida
Insurance Accepted
- Aetna Choice POS II
Aetna HMO
AvMed Health Open Access
BCBS Blue Card PPO
BCBS Florida BlueCare HMO
BCBS Florida NetworkBlue
BCBS Florida Preferred Patient Care PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPOCoventry Florida - Employer Group PPO
First Health PPO
Great West PPO
Health Net Oregon PPO
Humana ChoiceCare Network PPO
Multiplan PHCS PPO
Multiplan PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: